Strs Ohio Acumen Pharmaceuticals, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$3.08 - $4.88 $127,204 - $201,544	-41,300 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$3.91 - $6.73 $31,280 - $53,840	8,000 Added 24.02%	41,300 $161,000
Q4 2021 Jan 24, 2022	BUY	$6.54 - $15.31 $203,394 - $476,141	31,100 Added 1413.64%	33,300 $225,000
Q3 2021 Oct 22, 2021	BUY	$14.5 - $20.28 $31,900 - $44,616	2,200 New	2,200 $32,000

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $95.6M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.